Atlas Trials

Effects of Triiodothyronine (T3) in Ischemic Heart Failure

Clinical trial NCT05384847 · COMPLETED

Trial details

NCT number
NCT05384847
Sponsor
Emory University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Heart Failure
Start date
2022-12-02
Primary completion
2025-10-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.